Because sustaining proliferative signaling is another hallmark of cancer [18], we explored the receptor tyrosine kinase (RTK) signal pathways by analyzing genes known to promote the EGFR, FGFR, and PDGFR signaling commonly seen in malignant gliomas [2, 20]. The gene discussed is EGFR; the disease is cancer.